for subscribers

More vaccine hope

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!

Moderna Inc’s experimental vaccine was 94,5% effective in preventing Covid-19 based on interim data from a late-stage trial, the company said yesterday, becoming the second U.S. drugmaker to report results that far exceed expectations.

Together with Pfizer Inc’s vaccine, which is also more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorised for emergency use in December with as many as 60 million doses of vaccine available this year.

Next year, the U.S. government could have access to more than one billion doses just from the two vaccine makers — more than needed for the country’s 330 million residents.

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
Lockdown For
DAYS
HRS
MINS
Voting Booth
Will you continue to use WhatsApp following the company announcing a change terms of service which would force users to share personal data?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, the terms of service do not bother me enough to switch
53% - 7915 votes
No, I will be switching over to a new service
43% - 6555 votes
I've never used WhatsApp
4% - 600 votes
Vote
ZAR/USD
14.99
(+0.96)
ZAR/GBP
20.39
(+0.87)
ZAR/EUR
18.16
(+0.70)
ZAR/AUD
11.55
(+0.76)
ZAR/JPY
0.14
(+1.36)
Gold
1842.00
(+0.36)
Silver
25.32
(+1.46)
Platinum
1099.00
(+1.26)
Brent Crude
54.74
(-0.64)
Palladium
2380.50
(+0.85)
All Share
63772.62
(+0.09)
Top 40
58587.02
(+0.07)
Financial 15
11919.91
(+0.13)
Industrial 25
85001.80
(+0.22)
Resource 10
63134.38
(-0.13)
All JSE data delayed by at least 15 minutes morningstar logo